On Friday, Cellular Biomedicine Group Inc (NASDAQ:CBMG)’s shares gained 5.32% to $28.95, while its weekly performance remained poor, showing the downward trend up to -19.94%, as Cellular Biomedicine Group Inc (CBMG), declared that they have been selected to present at the seventh annual ChinaBio(R) Partnering Forum 2015 to be held in Shanghai (April 15-16, 2015) at the Kerry Hotel Pudong in Shanghai, China. This life science industry event is predictable to attract over 800 attendees from around the world focused on developing cross-border relationships in China.
Companies were selected to present based on their products, technologies or services providing high-value to multinational or domestic companies doing business in China. William (Wei) Cao, PhD, BM, Chief Executive Officer of the Corporation, will present “Realizing the Potential of Cell-Based Therapy Technology” on April 16th at 3:15pm.
Cellular Biomedicine Group Inc., a biomedicine corporation, develops treatments for cancerous and degenerative diseases in Greater China. It focuses on developing and marketing cell-based therapies to treat serious chronic and degenerative diseases, such as cancer, osteoarthritis, tissue damage, various inflammatory diseases, and metabolic diseases.
Inventergy Global Inc (NASDAQ:INVT)’s shares dropped -2.96% to $0.393, during the last trading session on Friday, while its weekly performance remained poor, showing the downward trend up to -17.02%, as Inventergy Global Inc (INVT), declared that it has reached definitive contracts with several institutional investors and accredited investors to purchase a total of $2.15 million of ordinary stock of the Corporation, comprising of 4,673,914 shares of ordinary stock at $0.46. Gross proceeds will be about $2.15 million, which the Corporation intends to use for working capital purposes in support of its intellectual property (IP) licensing strategies. The closing of the offering is predictable to take place on or before April 7, 2015, and is subject to the satisfaction of customary closing conditions.
Joe Beyers, Chairman and CEO of Inventergy, said, “We are extremely happy by this round of funding that provides us additional resources to pursue the various deals in our current pipeline. This strengthens our ability to move those talk aboutions along. We look forward to keeping our shareholders and prospective investors updated and are committed to becoming the leading industry standard in technology IP licensing.”
Ladenburg Thalmann & Co. Inc., a partner of Ladenburg Thalmann Financial Services Inc. (NYSE MKT: LTS), acted as exclusive placement agent in connection with the offering.
Inventergy Global, Inc. operates as an intellectual property (IP) investment and licensing corporation. The corporation identifies, attains, and licenses the patented technologies of technology companies.
At the end of Friday’s trade, Cinedigm Corp (NASDAQ:CIDM)‘s shares dipped -2.21% to $1.33, while its weekly performance remained poor, showing the downward trend up to -14.74%, on April 03, Cinedigm Corp (CIDM), declared a joint venture with the new horror-focused subscription based digital streaming service, THE CRYPT (www.enterthecrypt.com) presently accessible on the XBOX 360 and soon to be accessible on the corporation’s website and other platforms), to provide the emerging SVOD channel with titles from Cinedigm’s vast library of film and TV episodes.
In celebration of the new partnership, THE CRYPT will be offering a free month of unlimited horror movies for anyone who signs up using coupon code CRYPTFREEMONTH in the next 7 days.
Cinedigm Corp. distributes independent movie, television, and other short form content in the Unites States. It manages a library of distribution rights to about 52,000 titles and episodes released across theatrical, digital, physical, home, and mobile entertainment platforms, in addition to services digital cinema assets on about 12,000 movies screens. The corporation operates in four segments: Phase I Deployment, Phase II Deployment, Services, and Content & Entertainment.
Willbros Group Inc (NYSE:WG), ended its Friday’s trading session with -0.38% loss, and closed at $2.63, while its weekly performance remained poor, showing the downward trend up to -13.77%, as Willbros Group Inc (WG), declared results for the fourth quarter and full year 2014. The Corporation stated a net loss in the fourth quarter of $36.0 million, or $0.72 per share, on proceed of $450.7 million, contrast to a net profit of $12.8 million, or $0.27 per share, on proceed of $505.1 million for the same period in 2013. The fourth quarter results comprised of a $14.2 million, or $0.28 per share, non-cash debt extinguishment charge, and other charges of about $7.0 million, or $0.14 per share, associated with the investigation behind the deterioration of certain construction projects and employee severance costs associated with headcount reductions. For the full year 2014, the Corporation stated a net loss attributable to Willbros Group, Inc. of $79.8 million, or $1.62 per share, on proceed of $2.0 billion, contrast to a net loss of $15.9 million, or $0.32 per share, on proceed of $1.9 billion in 2013, which comprised of a non-cash debt extinguishment charge of $11.6 million, or $0.23 per share. Fiscal 2014 results comprised of non-cash debt extinguishment charges of $15.2 million, or $0.31 per share, primarily associated with the refinancing of our credit facilities. The fourth quarter generated an operating loss of $15.1 million contrast to operating revenue of $15.4 million in 2013, and the full year 2014 generated an operating loss of $2.8 million contrast to operating revenue of $31.5 million in 2013.
Willbros Group, Inc., together with its auxiliaries, operates as an energy infrastructure contractor serving the oil, gas, refining, petrochemical, and power industries in the United States and internationally. It provides engineering, procurement, and construction (EPC); and turnarounds, maintenance, facilities development, and operations services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
